Cancer staging is all about understanding how far cancer has spread in the body. For most solid tumours—like those found in the breast, lung, colon, and prostate- doctors typically classify them into four stages, ranging from Stage 1 to Stage 4. These stages are crucial as they help medical professionals evaluate the prognosis and decide on the best treatment options.
Let us walk through each stage briefly:
The 4-stage system is the most commonly used, but the cancer type and available diagnostic tools determine additional staging concepts.
Before we dive into Stage 1, it is worth mentioning that there can be a Stage 0, often referred to as carcinoma in situ. This stage is all about those abnormal cells that are hanging around but have not yet made their way into nearby tissues. Researchers often spot this in conditions like cervical intraepithelial neoplasia and breast ductal carcinoma in situ (DCIS). Although stage 0 cancer does not technically invade tissues, experts view it as a precursor that could advance if left untreated.
The American Joint Committee on Cancer (AJCC) developed the TNM system, which classifies the stages of different cancers. This system divides cancer into three main components:
The combination of these TNM values is used to determine the overall stage from 1 to 4. For example, cancer classified as T3, N1, or M0 is typically a Stage 3 tumour.
The 1–4 staging approach is not generally applicable to all types of cancer. Leukaemia, lymphoma, and multiple myeloma are examples of blood cancers that have their classification schemes. For instance, the number of lymph node areas affected and whether the disease is above or below the diaphragm determine the stage of Hodgkin lymphoma, which ranges from I to IV.
Depending on how severe the disease is, leukaemia can be classified into different phases, such as blast, rapid, or chronic.
Overall, understanding how cancer is staged, whether through the traditional four-stage system, the inclusion of Stage 0, or detailed TNM classifications, provides vital clarity for both patients and doctors.
These stages offer a structured way to assess how far the disease has progressed and what treatment paths may be most effective. By accurately determining the stage, medical teams can better plan care, and individuals can gain a clearer picture of what lies ahead.